Sartorius Stedim Biotech SA (OTCPK:SDMHF)
$ 220 0 (0%) Market Cap: 21.58 Bil Enterprise Value: 25.42 Bil PE Ratio: 60.71 PB Ratio: 7.62 GF Score: 97/100

Q4 2020 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript

Jan 27, 2021 / 02:30PM GMT
Release Date Price: $403 (-2.49%)
Operator

Good day, and welcome to Sartorius and Sartorius Stedim Biotech Conference Call on the Preliminary Full Year 2020 Results. Today's conference is being recorded.

At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.

Joachim Kreuzburg
Sartorius Aktiengesellschaft - Chairman of Executive Board & CEO

Thank you very much, and welcome, everybody, to our -- today's call and our preliminary results for 2020. As always, at this time of the year, together with Rainer, our CFO, we would like to inform you about the preliminary results of last year. And in addition to that, also give you a guidance for the year 2021. This time, as we already announced half a year ago, when we talked about our half year's figures for last year, we'll also give you an update on our midterm ambition for the year 2025. We will do that first for the Sartorius Group, and then thereafter directly present on the Sartorius Stedim Biotech set of numbers in all those 3 dimensions. And then after that, we are happy to take your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot